关注
Peter P. Toth, MD, PhD, FAHA, FESC, FACC
Peter P. Toth, MD, PhD, FAHA, FESC, FACC
Adjunct Professor of Medicine, Division of Cardiology, Johns Hopkins University School of Medicine
在 jhmi.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on …
AC Goldberg, PN Hopkins, PP Toth, CM Ballantyne, DJ Rader, ...
Journal of clinical lipidology 5 (3), 133-140, 2011
9932011
Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile
SS Martin, MJ Blaha, MB Elshazly, PP Toth, PO Kwiterovich, ...
Jama 310 (19), 2061-2068, 2013
8392013
Obesity, adiposity, and dyslipidemia: a consensus statement from the National Lipid Association
HE Bays, PP Toth, PM Kris-Etherton, N Abate, LJ Aronne, WV Brown, ...
Journal of clinical lipidology 7 (4), 304-383, 2013
6082013
Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation
GF Watts, S Gidding, AS Wierzbicki, PP Toth, R Alonso, WV Brown, ...
International journal of cardiology 171 (3), 309-325, 2014
5822014
Statin intolerance–an attempt at a unified definition. Position paper from an International Lipid Expert Panel: This paper is also published in parallel in Archives of Medical …
M Banach, M Rizzo, PP Toth, M Farnier, MH Davidson, K Al-Rasadi, ...
Expert opinion on drug safety 14 (6), 935-955, 2015
5672015
Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel
AFG Cicero, A Colletti, G Bajraktari, O Descamps, DM Djuric, M Ezhov, ...
Nutrition reviews 75 (9), 731-767, 2017
5152017
Friedewald-estimated versus directly measured low-density lipoprotein cholesterol and treatment implications
SS Martin, MJ Blaha, MB Elshazly, EA Brinton, PP Toth, JW McEvoy, ...
Journal of the American College of Cardiology 62 (8), 732-739, 2013
4472013
Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia
PN Hopkins, PP Toth, CM Ballantyne, DJ Rader
Journal of clinical lipidology 5 (3), S9-S17, 2011
4412011
Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists
MH Davidson, CM Ballantyne, TA Jacobson, VA Bittner, LT Braun, ...
Journal of clinical lipidology 5 (5), 338-367, 2011
4342011
High-density lipoproteins: a consensus statement from the National Lipid Association
PP Toth, PJ Barter, RS Rosenson, WE Boden, MJ Chapman, M Cuchel, ...
Journal of clinical lipidology 7 (5), 484-525, 2013
3702013
Ezetimibe therapy: mechanism of action and clinical update
BAP Phan, TD Dayspring, PP Toth
Vascular health and risk management, 415-427, 2012
3572012
Prevalence of lipid abnormalities in the united states: the national health and nutrition examination survey 2003–2006
PP Tóth, D Potter, EE Ming
Journal of clinical lipidology 6 (4), 325-330, 2012
3422012
Subclinical atherosclerosis: what it is, what it means and what we can do about it
PP Toth
International journal of clinical practice 62 (8), 1246-1254, 2008
3072008
Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: a pooled analysis of over 21,000 …
D Morrone, WS Weintraub, PP Toth, ME Hanson, RS Lowe, J Lin, ...
Atherosclerosis 223 (2), 251-261, 2012
2982012
Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease
PP Toth
Vascular health and risk management, 171-183, 2016
2692016
Residual macrovascular risk in 2013: what have we learned?
JC Fruchart, J Davignon, MP Hermans, K Al-Rubeaan, P Amarenco, ...
Cardiovascular Diabetology 13, 1-17, 2014
2432014
Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trials
M Banach, C Serban, A Sahebkar, S Ursoniu, J Rysz, P Muntner, PP Toth, ...
Mayo Clinic Proceedings 90 (1), 24-34, 2015
2312015
The “good cholesterol” high-density lipoprotein
PP Toth
Circulation 111 (5), e89-e91, 2005
2302005
Prevalence of statin intolerance: a meta-analysis
I Bytyçi, PE Penson, DP Mikhailidis, ND Wong, AV Hernandez, ...
European heart journal 43 (34), 3213-3223, 2022
2262022
High triglycerides are associated with increased cardiovascular events, medical costs, and resource use: a realworld administrative claims analysis of statintreated patients …
PP Toth, C Granowitz, M Hull, D Liassou, A Anderson, S Philip
Journal of the American Heart Association 7 (15), e008740, 2018
2152018
系统目前无法执行此操作,请稍后再试。
文章 1–20